The worldwide burden of HIV in transgender individuals: An updated systematic review and meta-analysis
Top Cited Papers
Open Access
- 1 December 2021
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (12) , e0260063
Abstract
Introduction: Transgender individuals are at risk for HIV. HIV risks are dynamic and there have been substantial changes in HIV prevention (e.g., pre-exposure prophylaxis [PrEP]). It is thus time to revisit HIV prevalence and burden among transgender individuals. The objective of this systematic review and meta-analysis was thus to examine worldwide prevalence and burden of HIV over the course of the epidemic among trans feminine and trans masculine individuals. Methods: We conducted an updated systematic review by searching PsycINFO, PubMed, Web of Science, and Google Scholar, for studies of any research design published in in a peer-reviewed journal in any language that reported HIV prevalence among transgender individuals published between January 2000 and January 2019. Two independent reviewers extracted the data and assessed methodological quality. We then conducted a meta-analysis, using random-effects modelling, to ascertain standardized prevalence and the relative burden of HIV carried by transgender individuals by country and year of data collection, and then by geographic region. We additionally explored the impact of sampling methods and pre-exposure prophylaxis (PrEP). Results: Based on 98 studies, overall standardized HIV prevalence over the course of the epidemic, based on weights from each country by year, was 19.9% (95% CI 14.7% - 25.1%) for trans feminine individuals (n = 48,604) and 2.56% (95% CI 0.0% - 5.9%) for trans masculine individuals (n = 6460). Overall OR for HIV infection, compared with individuals over age 15, was 66.0 (95% CI 51.4–84.8) for trans feminine individuals and 6.8 (95% CI 3.6–13.1) for trans masculine individuals. Prevalence varied by geographic region (13.5% - 29.9%) and sampling method (5.4% - 37.8%). Lastly, PrEP effects on prevalence could not be established. Conclusion: Trans feminine and trans masculine individuals are disproportionately burdened by HIV. Their unique prevention and care needs should be comprehensively addressed. Future research should further investigate the impact of sampling methods on HIV prevalence, and monitor the potential impact of PrEP.Keywords
Funding Information
- Aidsfonds (P-30805)
- Aidsfonds (P-30805)
This publication has 127 references indexed in Scilit:
- Increasing condom use and declining STI prevalence in high-risk MSM and TGs: evaluation of a large-scale prevention program in Tamil Nadu, IndiaBMC Public Health, 2013
- Comparing risk factors of HIV among hijra sex workers in Larkana and other cities of Pakistan: an analytical cross sectional studyBMC Public Health, 2012
- A prospective study of complications from comprehensive abortion care services in NepalBMC Public Health, 2012
- Recalled Sexual Experiences in Childhood with Older Partners: A Study of Brazilian Men Who Have Sex with Men and Male-to-Female Transgender PersonsArchives of Sexual Behavior, 2011
- Incidence of HIV Type 1 Infection, Antiretroviral Drug Resistance, and Molecular Characterization in Newly Diagnosed Individuals in Argentina: A Global Fund ProjectAIDS Research and Human Retroviruses, 2011
- HIV Prevalence, Risk Behavior, Hormone Use and Surgical History Among Transgender Persons in ThailandAIDS and Behavior, 2010
- Lifetime Risk Factors for HIV/Sexually Transmitted Infections Among Male-to-Female Transgender PersonsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- “There's No Pamphlet for the Kind of Sex I Have”: HIV-Related Risk Factors and Protective Behaviors Among Transgender Men Who Have Sex With Nontransgender MenJournal of the Association of Nurses in AIDS Care, 2009
- Prevalence and Risk Factors Associated with HIV Infection Among Men Having Sex with Men in Ho Chi Minh City, VietnamAIDS and Behavior, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003